Technical
Regulatory authorities have approved the use of recombinant monoclonal antibodies (mAbs) to treat infectious diseases1 and chronic conditions...
Anelis Quintana Cantillo, MSc
Anelis Quintana Cantillo, MSc, holds a bachelor’s degree in biology and a master’s degree in drug technology and control, both from Havana University. Anelis currently works in the R&D BioProcess Development Department at the Center of Molecular Immunology in Havana. Anelis has expertise in mammalian cell culture and fermentation processes development, laboratory-scale purification of monoclonal antibodies, and quantification and analytical characterization of monoclonal antibodies by ELISA, weak cation exchange chromatography and gel filtration in HPLC, SDS-PAGE, western blot, etc.
Related Articles